Nov 13, 2016

Synthetic virus may drive personalized medicine into precision medicine

Posted by in category: biotech/medical

A collaborative effort involving Auburn University, Gen9 and Autodesk has developed a synthetic viral genome for bone cancer research and one which may prove revolutionary in the battle against cancer overall.

The sCAV2 virus, which is the longest functional virus created in oncology research, targets and destroys selected tumor cells while not impacting healthy cells, notes an announcement.

“This could change the way we fight cancer. It is that revolutionary,” states Dr. Bruce Smith, a professor in the department of pathobiology and director of the Auburn University Research Initiative in Cancer, in the announcement. “Our concept is taking personalized medicine to precision medicine. The technology to create a new virus by synthesizing it is a huge leap, but the ability to then make a customized virus tailored to the specific needs of each patient will be transformative.”

Read more

Comments are closed.